SCHEMBL8656271

SCHEMBL8656271

NP(N)(=O)NC(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.67

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
PTGS1 P23219 5/20 0.53
TRPV1 Q8NER1 2/20 0.49
SRD5A2 P31213 1/20 0.48
RORC P51449 1/20 0.47
PTPN1 P18031 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
GSK3B P49841 2/20 0.47
TLR7 Q9NYK1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10936559 0.85 MPO (0.44)
SCHEMBL11435029 0.81 NPSR1 (0.59) CES2PTGS1RAB9A
SCHEMBL11441697 0.81 HDAC1 (0.60) TRPV1SRD5A2NPC1RAB9A
Flurofamide SCHEMBL635029 0.80 MEN1 (0.50) CES2CES1PTPN1NPC1RAB9A
SCHEMBL11435601 0.78 LMNA (0.55) PTGS1NPC1RAB9A
SCHEMBL182755 0.78 CES2 (0.61) CES2CES1PTGS1TRPV1SRD5A2
SCHEMBL1504927 0.76 KDM4E (0.61) CES2CES1
SCHEMBL8656312 0.76 ALDH1A1 (0.59) CES2CES1NPC1RAB9A
SCHEMBL14880225 0.75 CES2 (0.64) CES2CES1PTGS1TRPV1SRD5A2
SCHEMBL4174548 0.75 CES2 (0.64) CES2CES1PTGS1TRPV1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998042347-A1 PHARMACEUTICAL COMPOSITION CONTAINING A PHOSPHORYLAMIDE AND AN AYNTIBIOTIC TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-01 WO disclosed
EP-0852498-A1 PHOSPHORYLAMIDES, THEIR PREPARATION AND USE Takeda Chemical Industries, Ltd. (JP) 1998-07-15 EP disclosed
WO-1997011705-A1 PHOSPHORYLAMIDES, THEIR PREPARATION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-04-03 WO disclosed